Strategies for antifungal treatment failure in intensive care units

Der Anaesthesist
C ArensC Lichtenstern

Abstract

Recent epidemiologic studies reveal both an increasing incidence and an escalation in resistance of invasive fungal infections in intensive care units. Primary therapy fails in 70 % of cases, depending on the underlying pathogens and diseases. The purpose of this review is to raise awareness for the topic of antifungal therapy failure, describe the clinical conditions in which it occurs, and suggest a possible algorithm for handling the situation of suspected primary therapy failure.

References

Feb 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M Pfaller, J Riley
Feb 15, 1992·American Journal of Ophthalmology·L LaatikainenK von Dickhoff
Nov 1, 1984·Reviews of Infectious Diseases·R A SmegoD T Durack
Jan 1, 1995·Scandinavian Journal of Rheumatology·B L Hansen, K Andersen
May 27, 1994·Transplantation·R MañezT E Starzl
Jan 1, 1995·Antimicrobial Agents and Chemotherapy·J H RexM A Pfaller
Apr 1, 1995·American Journal of Ophthalmology·J K LuttrullH A Oster
Mar 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M E AklerW L Gold
Oct 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J H RexR G Washburn
Jan 1, 1995·Scandinavian Journal of Infectious Diseases·J O JarløvB Bruun
Aug 1, 1996·The American Journal of Medicine·E J AnaissieG P Bodey
Jul 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C HennequinB Charpentier
May 1, 1997·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·P PhillipsS Ioannou
Mar 26, 1998·Seminars in Arthritis and Rheumatism·A Pérez-GómezJ L Andreu
Dec 30, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M EllisB Vandercam
Jan 5, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C A KauffmanW E Dismukes
Jan 5, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J D SobelW E Dismukes
Jun 7, 2000·The Journal of Infection·M J AleixoM L Ferreira
Dec 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M E EllisW Ventura
Jul 20, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D J Miller, G C Mejicano
Dec 6, 2001·The Journal of Antimicrobial Chemotherapy·A Gómez-LópezJ L Rodriguez-Tudela
Jan 25, 2002·The New England Journal of Medicine·Thomas J WalshUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group
Jan 25, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David W DenningHartmut Lode
Apr 17, 2002·Clinical Pharmacology and Therapeutics·Alain J RomeroNolan Wood
Jul 30, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Raleigh BowdenJohn R Wingard
Aug 9, 2002·The New England Journal of Medicine·Raoul HerbrechtUNKNOWN Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillu
Aug 17, 2002·Antimicrobial Agents and Chemotherapy·Raman VenkataramananNina Singh
Oct 31, 2002·Clinical Pharmacokinetics·Peter De PaepeWalter A Buylaert
Nov 19, 2002·Antimicrobial Agents and Chemotherapy·David GoldblumStefan Zimmerli
Dec 20, 2002·The New England Journal of Medicine·Jorge Mora-DuarteUNKNOWN Caspofungin Invasive Candidiasis Study Group
Feb 21, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Leonard B Johnson, Carol A Kauffman
Mar 11, 2003·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·B P HowdenA M Mijch
Apr 18, 2003·The New England Journal of Medicine·Greg S MartinMarc Moss
Apr 26, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John R PerfectElizabeth Johnson
May 15, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John H RexUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group
May 27, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stanley C Deresinski, David A Stevens
Jul 3, 2003·The Journal of Antimicrobial Chemotherapy·Gunnar KahlmeterAlkiviadis Vatopoulos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.